NASDAQ · Technology · Fiscal year endsFY ends December

DNA X Inc

SONM

$2.59-0.11 (-4.07%)Today

52-week low $2.52high $11.90

78.2% below its 52-week high

What changed

The risk factors in the latest annual report, against the year before

Comparing the risk factors in DNA X Inc's annual report filed April 15, 2026 with the year before's. That means reading two long documents from the SEC; refresh in a minute.

Filings with the SEC

Every recent report

All Annual and quarterly reports Current reports (8-K)Insider trades (Form 4)Proxy statements

Filed	Form	What it is	Period or event
Sep 19, 2025	DEF 14A	Proxy statement	Sep 19, 2025
Jun 5, 2024	DEF 14A	Proxy statement	Jun 5, 2024
Aug 18, 2023	DEF 14A	Proxy statement	Aug 18, 2023
Sep 26, 2022	DEF 14A	Proxy statement	Sep 26, 2022
May 23, 2022	DEF 14A	Proxy statement	Jun 28, 2022
Sep 23, 2021	DEF 14A	Proxy statement	Oct 26, 2021
Aug 24, 2020	DEF 14A	Proxy statement	Sep 29, 2020

The SEC's list of DNA X Inc's recent filings reaches back to May 14, 2019; registration statements and other prospectus filings aren't shown. Every filing on EDGAR

The comparison takes Item 1A (risk factors) of the latest 10-K and of the one before it, splits each into paragraphs, and matches every paragraph to its closest counterpart by the words they share. Dates and figures are set aside, so a paragraph whose only change is the year counts as unchanged. It is done by rules, not by anyone’s reading: the sentences are the company’s own, quoted as filed.